Company intelligence / Profile preview
Hangzhou Aida Pharmaceuticals
Hangzhou, Zhejiang, Chinaaidapharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hangzhou Aida Pharmaceuticals is a Chinese biopharmaceutical company specializing in the research, development, and commercialization of innovative anti-tumor medications. Founded in 2002 and headquartered in Hangzhou, the company focuses on small molecule targeted therapies and DNA-interacting agents. Its lead candidate, Amonafide L-malate, has been investigated in late-stage clinical trials for indications such as acute myeloid leukemia and various solid tumors. The company aims to address unmet medical needs in oncology through its dedicated R&D center and manufacturing capabilities located in the Hangzhou Hi-Tech Zone.
- Therapeutic areas
- HematologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Hangzhou Aida Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Aida Pharmaceuticals.